ABSTRACT
Sporotrichosis is the most frequent subcutaneous mycosis in Mexico. The clinical forms are commonly described as lympho-cutaneous and cutaneous-fixed. The case of a male patient who developed an eritematous plaque with radial growth is reported. The patient received empirical therapy and topic steroids which modified the clinical picture with vesicles to vesicles, ulcers and blood and honey crusts. Diagnosis of fixed cutaneous sporotrichosis incognito was established by clinical, mycological and histopathological studies. Delayed cellular immunity in vitro and in vivo were normal. The patient received oral itraconazole showing clinical and mycological cure after four months.
Subject(s)
Sporothrix/isolation & purification , Sporotrichosis/diagnosis , Aged , Antifungal Agents/therapeutic use , Humans , Immunocompetence , Itraconazole/therapeutic use , Male , Mexico , Remission Induction , Sporotrichosis/drug therapy , Sporotrichosis/immunology , Sporotrichosis/microbiologyABSTRACT
Se reporta un estudio clínico, doble ciego, controlado, para evaluar la eficacia y seguridad de ivermectina por vía bucal a la dosis de 200 mcg/kg de peso para el tratamiento de la escabiasis, efectuado en 55 pacientes. Los resultados informaron que 26 pacientes (79.3 por ciento) curaron con ivermectina en su primera visita de control, en comparación con cuatro (16 por ciento) del grupo que recibió placebó (X²= 77.07, p<0.001). Al final 37 pacientes de 50 (74 por ciento tratados con ivermectina curaron comparados con cuatro de 26 (16 por ciento) manejados con placebo. Esta diferencia es significativa (X²=23.66, p<0.001). Se concluyó que la ivermectina por vía oral efectiva y segura en el tratamiento de la escabiasis